Diabetes Mellitus, Insulin-Dependent
|
0.460 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.
|
21829393 |
2011 |
Diabetes Mellitus, Insulin-Dependent
|
0.460 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.
|
21980299 |
2011 |
Diabetes Mellitus, Insulin-Dependent
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
The SH2B3 784T>C variant could contribute to the pathogenesis of T1D through impaired immune response that promotes activation and expansion of self-reactive lymphocytes in susceptible individuals.
|
20546165 |
2011 |
Diabetes Mellitus, Insulin-Dependent
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
PTPN22 (1p13.2), STAT4 (2q32.2), CTLA4 (2q33.2), HLA (6p21), IL2RA (10p15.1), INS (11p15.5), ERBB3 (12q13.2), SH2B3 (12q24.12), and CLEC16A (16p13.13) were convincingly associated with autoimmune diabetes in adults (P ≤ 0.002), with consistent directions of effect as reported for pediatric type 1 diabetes.
|
21873553 |
2011 |
Coronary Artery Disease
|
0.460 |
Biomarker
|
disease |
CTD_human |
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
|
21378990 |
2011 |
Diabetes Mellitus, Insulin-Dependent
|
0.460 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
|
19430480 |
2009 |
Diabetes Mellitus, Insulin-Dependent
|
0.460 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
|
19430480 |
2009 |
Diabetes Mellitus, Insulin-Dependent
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
The 32-bp insertion-deletion variant on chromosome 3p21 was newly identified as a type 1 diabetes locus (P=1.81x10(-8)) and was also associated with celiac disease, along with PTPN2 on chromosome 18p11 and CTLA4 on chromosome 2q33, bringing the total number of loci with evidence of a shared association to seven, including SH2B3 on chromosome 12q24.
|
19073967 |
2008 |
Myocardial Infarction
|
0.420 |
Biomarker
|
disease |
BEFREE |
MicroRNA-29b upregulation improves myocardial fibrosis and cardiac function in myocardial infarction rats through targeting SH2B3.
|
31799683 |
2019 |
Myocardial Infarction
|
0.420 |
Biomarker
|
disease |
CTD_human |
We also found that a nonsynonymous SNP at 12q24, in SH2B3, associated significantly (P = 8.6 x 10(-8)) with myocardial infarction in six different populations (6,650 cases and 40,621 controls).
|
19198610 |
2009 |
Myocardial Infarction
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
We also found that a nonsynonymous SNP at 12q24, in SH2B3, associated significantly (P = 8.6 x 10(-8)) with myocardial infarction in six different populations (6,650 cases and 40,621 controls).
|
19198610 |
2009 |
Myocardial Infarction
|
0.420 |
Biomarker
|
disease |
HPO |
|
|
|
Myocardial Infarction
|
0.420 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MYELODYSPLASTIC SYNDROME
|
0.410 |
AlteredExpression
|
group |
BEFREE |
The mutation prevalence rates of Janus kinase 2 and SH2B adaptor protein 3 were significantly higher in the MDS unclassified group and in the very high-risk groups with a karyotype as a prognostic indicator, respectively (both P<0.05).
|
31612018 |
2019 |
Cerebrovascular accident
|
0.410 |
GeneticVariation
|
group |
GWASCAT |
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.
|
29531354 |
2018 |
Cerebrovascular accident
|
0.410 |
Biomarker
|
group |
CTD_human |
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.
|
29531354 |
2018 |
Cerebrovascular accident
|
0.410 |
Biomarker
|
group |
BEFREE |
Our findings identify LNK as a stroke-specific, endogenous negative regulator of NSPC proliferation, and suggest that LNK signaling is a novel mechanism influencing plastic responses in postischemic brain.
|
22496561 |
2012 |
MYELODYSPLASTIC SYNDROME
|
0.410 |
Biomarker
|
group |
HPO |
|
|
|
MYELODYSPLASTIC SYNDROME
|
0.410 |
CausalMutation
|
group |
CGI |
|
|
|
MYELODYSPLASTIC SYNDROME
|
0.410 |
GenomicAlterations
|
group |
CGI |
|
|
|
Primary Myelofibrosis
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Primary Myelofibrosis
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Primary Myelofibrosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
Erythrocytosis familial, 1
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Erythrocytosis familial, 1
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|